Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07386418

Study of Lesion-Specific Invasive Haemodynamic Angina Thresholds

Led by Imperial College London · Updated on 2026-02-18

60

Participants Needed

6

Research Sites

N/A

Total Duration

On this page

Sponsors

I

Imperial College London

Lead Sponsor

S

St George's University Hospitals NHS Foundation Trust

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating how different coronary artery narrowings (stenoses) affect the threshold at which angina symptoms appear during exercise. This invasive study focuses on patients with stable angina who have two coronary stenoses suitable for treatment with percutaneous coronary intervention (PCI). The goal is to measure the angina threshold, defined as the level of blood flow reduction causing symptoms, using detailed physiological assessments during cardiac catheterization. The study involves inflating a balloon inside the coronary arteries during exercise on a supine ergometer to replicate the narrowing and measure the fractional flow reserve (FFR) and non-hyperemic pressure ratio (NHPR) at each stenosis. After stenting the arteries, the order of testing each lesion is randomized. The balloon is inflated gradually until angina symptoms occur, then deflated and removed. This procedure is repeated for both stenoses to compare their angina thresholds. Participants will undergo invasive coronary angiography, pressure wire measurements, and exercise testing during the procedure. Additional imaging such as computed tomography coronary angiography, quantitative coronary angiography, intravascular imaging, and cardiac magnetic resonance imaging will be done within 14 days to correlate anatomical features with the angina threshold. Researchers will also assess symptoms, quality of life, and pain perception. The primary outcome is the difference in FFR and NHPR angina thresholds measured during the procedure. The study is expected to continue until December 2028.

CONDITIONS

Brief Title

Study of Lesion-Specific Invasive Haemodynamic Angina Thresholds

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Eligible for PCI due to angina or angina-like symptoms during exercise
  • Have two severe epicardial coronary artery narrowings in a major artery with diameter 2.5mm or larger
  • Evidence of heart ischemia from invasive or non-invasive tests such as physiological tests during angiography, dobutamine stress echocardiography, stress perfusion cardiac MRI, myocardial perfusion scintigraphy, or fractional flow reserve CT
  • Adults aged 18 years or older
Not Eligible

You will not qualify if you...

  • Age under 18 years
  • Acute coronary syndrome within the last 3 months
  • Previous coronary artery bypass graft surgery
  • Significant disease in the left main coronary artery
  • Only a single lesion suitable for PCI
  • Chronic total blockage of the target artery
  • Moderate to severe heart valve disease
  • Left ventricular ejection fraction of 40% or less
  • Contraindications to PCI, drug-eluting stents, antiplatelet therapy, or adenosine
  • PCI performed with drug-eluting balloons without stenting
  • Unable to exercise on a supine ergometer
  • Access via femoral artery
  • Pregnancy
  • Unable to give informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Percutaneous Coronary Intervention (PCI)

Duration - Single day procedure

Participants undergo PCI to treat stable angina by managing coronary artery narrowings.

1 in-person procedure visit

Angina Threshold Measurement

Duration - Same day as PCI

Following PCI, participants have invasive angina threshold measurements using a balloon inflation and pressure wire during exercise to assess physiological responses.

1 intra-procedural assessment

Post-Procedural Imaging and Symptom Correlation

Duration - Up to 14 days after PCI

Participants undergo imaging and symptom assessments including CT coronary angiography, quantitative coronary angiography, cardiac MRI, and questionnaires to correlate with angina thresholds.

1 to 2 visits within 14 days

Trial Site Locations

Total: 6 locations

1

Mid and South Essex NHS Foundation Trust

Basildon, United Kingdom

Not Yet Recruiting

2

University Hospitals Dorset NHS Foundation Trust

Bournemouth, United Kingdom

Not Yet Recruiting

3

Imperial College Healthcare NHS Trust

London, United Kingdom

Actively Recruiting

4

Royal Free London NHS Foundation Trust

London, United Kingdom

Not Yet Recruiting

5

St George's University Hospitals NHS Foundation Trust

London, United Kingdom

Not Yet Recruiting

6

Portsmouth Hospitals University NHS Trust

Portsmouth, United Kingdom

Not Yet Recruiting

Loading map...

Research Team

K

Kayla Chiew, MBBS MRCP

R

Rasha Al-Lamee, MBBS PhD MRCP

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Similar Trials

ADVANCEd NanoTherapies SirPlux Duo22 Dual API-Coated PTCA B...

Angina (Stable)

Actively Recruiting

3 locations

Effect of Different Aerobic Exercise Methods in Cardiac Reha...

Percutaneous Coronary Intervention (PCI)

Actively Recruiting

2 locations

Assessment of Coronary Artery Disease Before Transcatheter A...

Aortic Valve Stenosis and Insufficiency

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here